Cargando…

Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation

Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder that results in irreversible renal damage due to 2,8-dihydroxyadenine (DHA) nephropathy. A 28-year-old man underwent living-related kidney transplantation for chronic kidney disease of unknown etiology. Numero...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanmoku, Koji, Kurosawa, Akira, Shinzato, Takahiro, Shimizu, Toshihiro, Kimura, Takaaki, Yagisawa, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498204/
https://www.ncbi.nlm.nih.gov/pubmed/28566603
http://dx.doi.org/10.2169/internalmedicine.56.8142
_version_ 1783248270520221696
author Nanmoku, Koji
Kurosawa, Akira
Shinzato, Takahiro
Shimizu, Toshihiro
Kimura, Takaaki
Yagisawa, Takashi
author_facet Nanmoku, Koji
Kurosawa, Akira
Shinzato, Takahiro
Shimizu, Toshihiro
Kimura, Takaaki
Yagisawa, Takashi
author_sort Nanmoku, Koji
collection PubMed
description Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder that results in irreversible renal damage due to 2,8-dihydroxyadenine (DHA) nephropathy. A 28-year-old man underwent living-related kidney transplantation for chronic kidney disease of unknown etiology. Numerous spherical brownish crystals observed in his urinary sediment on postoperative day 3 and were observed within the tubular lumen of renal allograft biopsy specimens on postoperative day 7. After a genetic diagnosis, febuxostat treatment was started on postoperative day 7, with the dosage gradually increased to 80 mg/day until complete the disappearance of 2,8-DHA crystals. Febuxostat prevented secondary 2,8-DHA nephropathy after kidney transplantation.
format Online
Article
Text
id pubmed-5498204
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-54982042017-07-07 Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation Nanmoku, Koji Kurosawa, Akira Shinzato, Takahiro Shimizu, Toshihiro Kimura, Takaaki Yagisawa, Takashi Intern Med Case Report Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder that results in irreversible renal damage due to 2,8-dihydroxyadenine (DHA) nephropathy. A 28-year-old man underwent living-related kidney transplantation for chronic kidney disease of unknown etiology. Numerous spherical brownish crystals observed in his urinary sediment on postoperative day 3 and were observed within the tubular lumen of renal allograft biopsy specimens on postoperative day 7. After a genetic diagnosis, febuxostat treatment was started on postoperative day 7, with the dosage gradually increased to 80 mg/day until complete the disappearance of 2,8-DHA crystals. Febuxostat prevented secondary 2,8-DHA nephropathy after kidney transplantation. The Japanese Society of Internal Medicine 2017-06-01 /pmc/articles/PMC5498204/ /pubmed/28566603 http://dx.doi.org/10.2169/internalmedicine.56.8142 Text en Copyright © 2017 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Nanmoku, Koji
Kurosawa, Akira
Shinzato, Takahiro
Shimizu, Toshihiro
Kimura, Takaaki
Yagisawa, Takashi
Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation
title Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation
title_full Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation
title_fullStr Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation
title_full_unstemmed Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation
title_short Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation
title_sort febuxostat for the prevention of recurrent 2,8-dihydroxyadenine nephropathy due to adenine phosphoribosyltransferase deficiency following kidney transplantation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498204/
https://www.ncbi.nlm.nih.gov/pubmed/28566603
http://dx.doi.org/10.2169/internalmedicine.56.8142
work_keys_str_mv AT nanmokukoji febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation
AT kurosawaakira febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation
AT shinzatotakahiro febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation
AT shimizutoshihiro febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation
AT kimuratakaaki febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation
AT yagisawatakashi febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation